
Please try another search
Feb 2 (Reuters) - Quest Pharmatech Inc QPT.V : * QUEST PROVIDES UPDATE TO IMMUNOTHERAPY ASSET TRANSFER BETWEEN ONCOQUEST INC. AND ONCOQUEST PHARMACEUTICALS INC. * QUEST PHARMATECH - FINAL PAYMENT OF...
April 22 (Reuters) - Quest Pharmatech Inc QPT.V : * ONCOQUEST SIGNS A DEFINITIVE AGREEMENT TO SELL DRUG PORTFOLIO TO DUAL INDUSTRIAL FOR U.S. $300 MILLION AND COMMITMENT TO FUND THE OREGOVOMAB PHASE 3...
March 24 (Reuters) - Quest Pharmatech Inc QPT.V : * ONCOQUEST ANNOUNCES PUBLICATION OF TWO REPORTS RELATED TO OREGOVOMAB PHASE 2 CLINICAL TRIAL, THE COMPANY'S LEAD INVESTIGATIONAL DRUG IN FRONTLINE...
Sept 25 (Reuters) - Quest Pharmatech Inc QPT.V : * ONCOQUEST RECEIVES "NOTICE OF ALLOWANCE" FOR PATENT PROTECTION OF THE ADMINISTRATION SCHEDULE OF OREGOVOMAB AND CHEMOTHERAPY FOR STAGE III-IV OVARIAN...
Dec 19 (Reuters) - Quest Pharmatech Inc QPT.V : * QUEST PHARMATECH ADOPTS AMENDMENT TO BY-LAWS REQUIRING ADVANCE NOTICE OF NOMINATION OF DIRECTORS * BY-LAW AMENDMENT IS EFFECTIVE IMMEDIATELY
Nov 28 (Reuters) - Quest Pharmatech Inc QPT.V : * QUEST PHARMATECH SIGNS LICENSE AGREEMENT WITH ONCOCARE THERAPEUTICS TO DEVELOP AND COMMERCIALIZE TARGETED CANCER THERAPY TECHNOLOGY IN THE U.S. *...
July 20 (Reuters) - Quest Pharmatech Inc QPT.V : * MADENCO BIOSCIENCES ANNOUNCES STRATEGIC DECISION TO DROP CONSUMER HEALTH PRODUCTS AND FOCUS ON PHARMACEUTICAL PRODUCT DEVELOPMENT * MADENCO...
Jan 3 (Reuters) - Quest Pharmatech Inc QPT.V : * QUEST PHARMATECH- UNIT SIGN EXCLUSIVE LICENSE AGREEMENT WITH STANFORD UNIVERSITY TO DEVELOP & COMMERCIALIZE PATENTED EGF WOUND HEALING TECHNOLOGY
May 9 (Reuters) - Quest Pharmatech Inc QPT.V : * Oncoquest announces enrollment of first patient in phase 1/2 clinical study using combination of oregovomab with checkpoint inhibitor nivolumab in...
May 4 (Reuters) - Quest PharmaTech Inc QPT.V : * Says making a $500,000 cash investment to acquire 32% of outstanding common stock of Natural Rf Life Sciences Inc Source text for Eikon:...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review